Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 25;12:687254. doi: 10.3389/fimmu.2021.687254

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Heidt, Haasnoot, van der Linden-van Oevelen and Claas

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The 15-year death censored graft survival of AM patients is similar to that of unsensitized patients. Selection was based on criteria described prior (16) and included: transplantation from 1996 onwards (start ETKAS allocation), minimum 1 HLA mismatch, kidney only, repeat transplants (since the vast majority of AM patients are repeat transplant candidates). Patients transplanted through ETKAS are subdivided into 0-5% PRA (non-sensitized), 6-85% PRA (intermediately sensitized), >85% PRA (highly sensitized, transplanted outside the AM program).